Acute manic psychosis induced by triple therapy for H. pylori.
Neff
Nancy E
NE
Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77005, USA.
Kuo
Grace
G
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000208:Acute Disease; D000658:Amoxicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000201:enzymology; D000068579:Celecoxib; D017291:Clarithromycin / Q000009:adverse effects; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects*; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D064747:Lansoprazole; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008875:Middle Aged; D009853:Omeprazole / Q000009:adverse effects / Q000031:analogs & derivatives*; D010406:Penicillins / Q000009:adverse effects; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D016861:Cyclooxygenase Inhibitors; D010406:Penicillins; D011720:Pyrazoles; D013449:Sulfonamides; D064747:Lansoprazole; D000658:Amoxicillin; D003577:Cytochrome P-450 Enzyme System; D017291:Clarithromycin; D000068579:Celecoxib; D009853:Omeprazole